Soy and Breast Cancer - Soy Consumption Linked to Lower Incidence of Cancer

Soy and breast cancer: why does some of us eat it more than others?

As global population continues to rise, so do our opportunities to become cancer patients. Globally, every year, about 9.6 million new cases of breast cancer are diagnosed and approximately 638,00 new cases occur each day. Breast cancer is the second most common cause of deaths due to female cancer, after lung cancer. According to the 2022 World Health Organization statistics, the diagnosis rate for breast cancer stands at 0.8%. It is estimated to account for 33% of all cancer diagnoses. According to some reports, there were ~6.3million deaths globally due to breast cancer in 2016. The number of diagnosed is increasing in the US with 2.6-18 million diagnosed since 1990 in US young women. Likewise, in European countries, 1,314,181 new breast cancer diagnosed in 29 other European countries from 7,572,055 US females diagnosed from 20 years or older in 1988. More than 2,600,542 US females were alive at the end of 1st quarter 2015 and >21.5 million US females live today. About 67% newly diagnosed were Caucasian in US while 17% in European. In Netherlands, 2454 new breast cancer cases a day by June 20th in 21 days from July 31, 2044 The mortality ratio among different races and ethnic groups is highly variable with Blacks (4–5%) and Indians (6–7%) having higher death rates compared to whites (2–3%). Blacks and Latinas (a 2% higher mortality rates compared with non-Latino Whites 2%), Hispanics (no differences in CRC death rates) and Asian-Americans (almost 2 x lower disease rates). Higher death rates are noted for whites living in Central (with 28.47 deaths per 1,00) versus other areas of the United States. Similarly higher death rate ratios are noted in women living in urban (39.72) compared with rural areas (13.92). According to CDC data, mean age at diagnosis has increased to 65 or older while disease stage at diagnosis reflects a relative increase in early stage (stage I/II) for black (BC) (45.85%) as an Asian vs. white (78.28%). Disease stage at diagnosis increased among other subgroups after age of 85 was adjusted for. Additionally early diagnosis of BC is seen by chance (e.g., higher first stages for late stage) by MST or MODS/CAP rates depending on underlying factors. Except with Asian where benefit is marginal. Similar to Asians, trend towards earlier diagnosis (≥